Hutch News

Hutch News

Stories tagged 'Breast Cancer'

Links between air pollution and cancer risk

An environmental exposure researcher on how the air we breathe can raise risk of lung and other cancers — and what to do about it

Aug. 18, 2017 | By Rachel Tompa / Fred Hutch News Service

Regular air pollution boosts our long-term risk of lung cancer. As wildfire season heats up from climate change, the Western U.S. air quality could suffer.

View story >


Q&A: Complex lessons about cancer risk from Holocaust survivors

Dr. Beti Thompson discusses studying the links between extreme traumatic events and disease

July 12, 2017 | By Sabin Russell / Fred Hutch News Service

Dr. Beti Thompson, of Fred Hutch's Health Disparities Research Center, discusses her editorial in Cancer about an Israeli study showing higher cancer risk among Holocaust survivors.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >


Filling in the gaps on an ‘understudied population’

First-ever estimate of women living with metastatic breast cancer shows these patients are living longer with disease

May 17, 2017 | By Diane Mapes / Fred Hutch News Service

Researchers at the National Cancer Institute and Fred Hutch have provided a first-ever estimate of how many women in the U.S. are currently living with metastatic breast cancer.

View story >


Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >


Finding ways to deliver on the promise of precision oncology

‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients

March 31, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.